GIULIA TOZZI

Dr. GIULIA TOZZI

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
FPFiorella Piemonte
Fiorella Piemonte
PAPastore Anna
Pastore Anna
GTGIULIA TOZZI
GIULIA TOZZI
DTD. Tagliacozzi
D. Tagliacozzi
FSF. M. Santorelli
F. M. Santorelli
EBEnrico Bertini
Enrico Bertini

1 November 2012 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
DMDiego Martinelli
Diego Martinelli
MCMichela Catteruccia
Michela Catteruccia
FPFiorella Piemonte
Fiorella Piemonte
PAPastore Anna
Pastore Anna
GTGIULIA TOZZI
GIULIA TOZZI
GMGuy Miller
Guy Miller

1 October 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PAPastore Anna
Pastore Anna
GTGIULIA TOZZI
GIULIA TOZZI
LGLaura Maria Gaeta
Laura Maria Gaeta
EBEnrico Bertini
Enrico Bertini
VSValentina Serafini
Valentina Serafini
FPFiorella Piemonte
Fiorella Piemonte
Increasing evidence suggests that iron-mediated oxidative stress might underlie the development of neurodegeneration in Friedreich's ataxia (FRDA), an autosomal recessive ataxia caused by decreased expression of frataxin, a protein implicated in iron metabolism. In this study, we demonstrate that, in fibroblasts of patients with FRDA, the cellular redox equilibrium is shifted toward more protein-bound glutathione. Furthermore, we found that actin is glutathionylated, probably as a result of the accumulation of reactive oxygen species, generated by iron overload in the disease. Indeed, high-pressure liquid chromatography analysis of control fibroblasts in vivo treated with FeSO4 showed a significant increase in the protein-bound/free GSH ratio, and Western blot analysis indicated a relevant rise in glutathionylation. Actin glutathionylation contributes to impaired microfilament organization in FRDA fibroblasts. Rhodamine phalloidin staining revealed a disarray of actin filaments and a reduced signal of F-actin fluorescence. The same hematoxylin/eosin-stained cells showed abnormalities in size and shape. When we treated FRDA fibroblasts with reduced glutathione, we obtained a complete rescue of cytoskeletal abnormalities and cell viability. Thus, we conclude that oxidative stress may induce actin glutathionylation and impairment of cytoskeletal functions in FRDA fibroblasts.

15 January 2004 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
FFFatima Ferreirinha
Fatima Ferreirinha
AQAngelo Quattrini
Angelo Quattrini
MPMarinella Pirozzi
Marinella Pirozzi
VVValentina Valsecchi
Valentina Valsecchi
GDGiorgia Dina
Giorgia Dina
ERElena I. Rugarli
Elena I. Rugarli
In several neurodegenerative diseases, axonal degeneration occurs before neuronal death and contributes significantly to patients’ disability. Hereditary spastic paraplegia (HSP) is a genetically heterogeneous condition characterized by selective degeneration of axons of the corticospinal tracts and fasciculus gracilis. HSP may therefore be considered an exemplary disease to study the local programs mediating axonal degeneration. We have developed a mouse model for autosomal recessive HSP due to mutations in the SPG7 gene encoding the mitochondrial ATPase paraplegin. Paraplegin-deficient mice are affected by a distal axonopathy of spinal and peripheral axons, characterized by axonal swelling and degeneration. We found that mitochondrial morphological abnormalities occurred in synaptic terminals and in distal regions of axons long before the first signs of swelling and degeneration and correlated with onset of motor impairment during a rotarod test. Axonal swellings occur through massive accumulation of organelles and neurofilaments, suggesting impairment of anterograde axonal transport. Retrograde axonal transport is delayed in symptomatic mice. We speculate that local failure of mitochondrial function may affect axonal transport and cause axonal degeneration. Our data suggest that a timely therapeutic intervention may prevent the loss of axons.

1 April 2016 in Kidney International
Verified
Journal Article
Closed access
LRLaura Rita Rega
Laura Rita Rega
EPElena Polishchuk
Elena Polishchuk
SMSandro Montefusco
Sandro Montefusco
GNGennaro Napolitano
Gennaro Napolitano
GTGIULIA TOZZI
GIULIA TOZZI
FEFrancesco Emma
Francesco Emma

1 May 2002 in Archives of Disease in Childhood
Verified
Journal Article
Open access
PDF file
GTGIULIA TOZZI
GIULIA TOZZI
MNM Nuccetelli
M Nuccetelli
MBM Lo Bello
M Lo Bello
SBS Bernardini
S Bernardini
LBL Bellincampi
L Bellincampi
FPFiorella Piemonte
Fiorella Piemonte
Background and Aims: Increased generation of reactive oxygen species and mitochondrial dysfunction may underlie the pathophysiology of Friedreich's ataxia, the most common inherited ataxia, due to GAA expansion in a gene coding for a mitochondrial protein (frataxin), implicated in the regulation of iron metabolism. Because iron overload would cause oxidative stress in Friedreich's ataxia, we investigated the enzyme antioxidant system in the blood of 14 patients by determining superoxide dismutase, glutathione peroxidase, and glutathione trasferase catalytic activities. We also studied the glutathione S-transferase genotype polymorphism in order to evaluate its possible influence on enzyme activity. Methods: Blood samples were obtained from 14 unrelated patients with Friedreich's ataxia and 21 age matched healthy subjects. Antioxidant enzyme determinations were spectrophotometrically assayed using specific substrates; the glutathione S-transferase genotype polymorphism was analysed by endonuclease restriction mapping of exon 5 and 6 amplification products. Results: There was a significant elevation of the superoxide dismutase/glutathione peroxidase activity ratio (0.037 (0.01) v 0.025 (0.008) of controls) and an 83% rise of glutathione transferase specific activity (0.22 (0.1) v 0.12 (0.03) nmol/min/mg protein) in blood of patients with Friedreich's ataxia than in the controls. The genotype polymorphism of glutathione S-transferase enzyme did not show any relevant differences when compared to that of healthy subjects. Conclusions: Data show an impairment in vivo of antioxidant enzymes in patients with Friedreich's ataxia and provide evidence of an increased sensitivity to oxidative stress, supporting a consistent role of free radical cytotoxicity in the pathophysiology of the disease.